Reversed sequence enhances antimicrobial activity of a synthetic peptide

Journal of Peptide Science

Volumn 17, Issue 5, 2011, Pages 329-334

  Gopal, Ramamourthy ^a   Kim, Young Jin ^b   Seo, Chang Ho ^b   Hahm, Kyung Soo ^a,c   Park, Yoonkyung ^a  

^a Chosun University   (South Korea)

^b Kongju National University   (South Korea)

^c Chosun University College of Medicine   (South Korea)

Author keywords

Antimicrobial activity; Leakage of calcein; Lys; Reversed peptide; Trp

Indexed keywords

PEPTIDE DERIVATIVE;

AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG STRUCTURE; HEMOLYSIS; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; CIRCULAR DICHROISM; FLUORESCEINS; HEMOLYSIS; HUMANS; LYSINE; MICROBIAL SENSITIVITY TESTS; TRYPTOPHAN;

EID: 79953797496     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1369     Document Type: Article

References (39)

1. Boman HG. Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med. 2003; 254: 197-215.
2. Hancock REW, Chapple DS. Peptide antibiotics. Antimicrob. Agents Chemother. 1999; 43: 1317-1323.
3. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
4. Wieprecht T, Dathe M, Beyermann M, Krause E, Maloy WL, MacDonald DL, Bienert M. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry 1997; 36: 6124-6132.
5. Giangaspero A, Sandri L, Tossi A. Amphipathic alpha helical antimicrobial peptides. Eur. J. Biochem. 2001; 268: 5589-5600.
6. Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS. Rational design of α-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 2005; 280: 12316-12329.
7. Zelezetsky I, Pacor S, Pag U, Papo N, Shai Y, Sahl HG, Tossi A. Controlled alteration of the shape and conformational stability of α-helical cell-lytic peptides: effect on mode of action and cell specificity. Biochem. J. 2005; 390: 177-188.
8. Zelezetsky I, Tossi A. Alpha-helical antimicrobial peptides-using a sequence template to guide structure-activity relationship studies. Biochem. Biophys. Acta 2006; 1758: 1436-1449.
9. Jiang Z, Vasil AI, Hale JD, Hancock RE, Vasil ML, Hodges RS. Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Biopolymers 2008; 90: 369-383.
10. Subbalakshmi C, Nagaraj R, Sitaram N. Biological activities of retro and diastereo analogs of a 13-residue peptide with antimicrobial and hemolytic activities. J. Pept. Res. 2001; 57: 59-67.
11. Lee J, Lee DG. Structure antimicrobial activity relationship between pleurocidin and its enantiomer. Exp. Mol. Med. 2008; 40: 370-376.
12. Wang Z, Wang G. APD: the antimicrobial peptide database. Nucl. Acid Res. 2004; 32:(Database issue): D590-D592.
13. Papo N, Oren Z, Pag U, Sahl HG, Shai Y. The consequence of sequence alternation of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. J. Biol. Chem. 2002; 277: 33913-33921.
14. Epand RF, Lehrer RI, Waring A, Wang W, Maget-Dana R, Lelievre D, Epand RM. Direct comparison of membrane interactions of model peptides composed of only Leu and Lys residues. Bioploymers 2003; 71: 2-16.
15. Park Y, Lee DG, Jang SH, Woo ER, Jeong HG, Choi CH, Hahm KS. A Leu-Lys-rich antimicrobial peptide: activity and mechanism. Biochim. Biophys. Acta 2003; 1645: 172-182.
16. Dathe M, Schumann M, Wieprecht T, Winkler A, Beyermann M, Krause E, Matsuzaki K, Murase O, Bienert M. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry 1996; 35: 12612-12622.
17. Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Biochemistry 2005; 44: 12094-12106.
18. Gopal R, Park SC, Ha KJ, Cho SJ, Kim SW, Song PI, Nah JW, Park Y, Hahm KS. Effect of leucine and lysine substitution on the antimicrobial activity and evaluation of the mechanism of the HPA3NT3 analog peptide. J. Pept. Sci. 2009; 15: 589-594.
19. Schibli DJ, Epand RF, Vogel HJ, Epand RM. Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions. Biochem. Cell Biol. 2002; 80: 667-677.
20. Atherton E, Sheppard RC. Solid Phase Peptide Synthesis: A Practical Approach. IRL: Oxford, 1989.
21. Jahn B, Martin E, Stueben A, Bhakdi S. Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide assay. J. Clin. Microbiol. 1995; 33: 661-667.
22. Park SC, Yoo NC, Kim JY, Park HK, Chae BJ, Shin SY, Cheong H, Park Y, Hahm KS. Isolation and characterization of an extracellular antimicrobial protein from Aspergillus oryzae. J. Agric. Food Chem. 2008; 56: 9647-9652.
23. Ghosh JK, Peisajovich SG, Ovadia M, Shai Y. Serum-induced leakage of liposome contents. J. Biol. Chem. 1998; 273: 27182-27190.
24. Mae D, Wallace BA. Differential light scattering and adsorption flattening optical effects are minimal in the circular dichroism spectra of small unilamellar vesicles. Biochemistry 1984; 23: 2667-2673.
25. Juvvadi P, Vunnam S, Merrifield RB. Synthetic melittin, its enantio, retro, and retroenantio isomers and selected chimeric analogs: their antibacterial, hemolytic, and lipid bilayer action. J. Am. Chem. Soc. 1996; 118: 8989-8997.
26. Ando S, Mitsuyasu K, Soeda Y, Hidaka M, Ito Y, Matsubara K, Shindo M, Uchida Y, Aoyagi H. Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. J. Pept. Sci. 2010; 16: 171-177.
27. Goldfeder Y, Zaknoon F, Mor A. Experimental conditions that enhance potency of an antibacterial oligo-acyl-lysyl. Antimicrob. Agents Chemother. 2010; 54: 2590-2595.
28. Iwahori A, Hirota Y, Sampe R, Miyano S, Numao N. Synthesis of reversed magainin 2 analogs enhanced antibacterial activity. Biol. Pharm. Bull. 1997; 20: 267-270.
29. Staubitz P, Peschel A, Nieuwenhuizen WF, Otto M, Götz F, Jung G, Jack RW. Structure-function relationships in the tryptophan-rich, antimicrobial peptide indolicidin. J. Pept. Sci. 2001; 7: 552-564.
30. Lee SH, Lee DG, Yang ST, Kim Y, Kim JI, Hahm KS, Shin SY. Antibiotic activity of reversed peptides of alpha-helical antimicrobial peptide, P18. Protein Pept. Lett. 2002; 9: 395-402.
31. Nagpal S, Kaur KJ, Jain D, Salunke DM. Plasticity in structure and interactions is critical for the action of indolicidin, an antibacterial peptide of innate immune origin. Protein Sci. 2002; 11: 2158-2167.
32. Wei SY, Wu JM, Kuo YY, Chen HL, Yip BS, Tzeng SR, Cheng JW. Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity. J. Bacteriol. 2006; 188: 328-334.
33. Ulvatne H, Karoliussen S, Stiberg T, Rekdal O, Svendsen JS. Short antibacterial peptides and erythromycin act synergically against Escherichia coli. J. Antimicrob. Chemother. 2001; 48: 203-208.
34. Epand RM, Vogel HJ. Diversity of antimicrobial peptides and their mechanisms of action. Biochem. Biophys. Acta 1999; 1462: 11-28.
35. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002; 66: 236-248.
36. Dathe M, Nikolenko H, Klose J, Bienert M. Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan- containing hexapeptides. Biochemistry 2004; 43: 9140-9150.
37. Woody RW. Contribution of tryptophan side chains to the far-ultraviolet circular dichroism of proteins. Eur. Biophys. J. 1994; 23: 253-262.
38. Ladokhin AS, Selsted ME, White SH. Bilayers interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids. Biophys. J. 1997; 72: 794-805.
39. Liu Z, Brady A, Young A, Rasimick B, Chen K, Zhou C, Kallenbach NR. Length effects in antimicrobial peptides of the (RW)n series. Antimicrob. Agents Chemother. 2007; 51: 597-603.